Skip to main content
. Author manuscript; available in PMC: 2015 Feb 1.
Published in final edited form as: Clin Gastroenterol Hepatol. 2013 Aug 23;12(2):327–333.e1. doi: 10.1016/j.cgh.2013.08.034

Table 1.

Baseline Characteristics of 308 Patients With Chronic HCV Genotype 1 Infection

Characteristic Distribution
Demographics
  Mean age, y (SD) 56.1 (5.5)
  Race, %
    Caucasian 75.0
    African American 25.0
Clinical characteristics, %
  FibroSURE-ActiTest
    F0–F3 61.6
    F3/F4–F4 38.4
  Necroinflammatory
    A0–A2 67.4
    A2/3–A3 32.6
  HCV genotype
    1 (unspecified) 3.6
    1a 70.1
    1b 26.3
Overall treatment ineligible, % 36.0
Reasons for treatment ineligibility, %
  Physical comorbidity 19.5
    Coronary artery disease 2.6
    Other cardiac conditions 0.3
    COPD 3.2
    ESRD 0.0
    Cancer 4.5
    Decompensated cirrhosis 4.5
    Othera 9.7
  Mental comorbidity 19.2
    Current drug/alcohol use 13.0
    Depression 10.1
    Other psychiatric diagnosesb 0.6
  Other barriers 8.4
    Noncompliance with evaluation 1.9
    Homelessness 0.3
    Noninterest in treatment 3.6
    Failed previous treatment 2.6
Eventually treated, % 11.0

COPD, chronic obstructive pulmonary disease; ESRD, end-stage renal disease.

a

Included were anemia, awaiting hip surgery, cerebrovascular disease, colitis, diabetes, glaucoma, hyperthyroidism, hypothyroidism, neutropenia, obesity, pancytopenia, peripheral vascular disease, retinal vein occlusion, seizures, suspicious mass, suspicious lesions, thrombosis, and thrombocytopenia.

b

Included memory issues.